<p>房地产投资信托基金（REITs）通常是收入投资者的最爱。它们提供定期分红，便于接触有形资产，并且可以作为对抗通货膨胀的自然对冲。在这个领域中，<strong>Global Medical REIT</strong> <strong>Inc. NYSE: GMRE</strong> 作为一个专注于医疗物业的细分市场参与者脱颖而出。其投资组合包括医疗办公楼、门诊设施和专科护理中心——所有这些都由长期租约和稳定的租户支持。</p>
<p>然而，对于投资者来说，令人沮丧的是，尽管这种实体稳定在纸面上看起来不错，但近年来对 Global Medical 的帮助不大。自 2021 年 12 月以来，其股价持续下跌，价值损失超过 60%。正如我们下面将看到的，多个因素导致了这一情况，并且该股票在本月早些时候创下了历史新低。</p>
<p>获取 <strong>Global Medical REIT</strong> 的提醒：</p>
<p>但经过多年的持续抛售，终于出现了底部形成的迹象。随着几位分析师开始转向看涨，技术面也在改善，有理由认为 Global Medical 期待已久的复苏终于开始成形。让我们深入了解一下。</p>
<h2>残酷的下行趋势，但明确的底部正在出现</h2>
<p>股票下跌的主要原因可以归因于更高的利率和投资者对负债沉重的房地产公司的怀疑，这使得空头特别青睐 Global Medical。今年早些时候，管理层被迫将股息削减 29%，这在股票整合时动摇了投资者的信心。</p>
<p>但尽管此后股价进一步下滑，该股票可能已经找到了底部。30 美元的水平现在已成为一个关键的支撑线；这是空头在去年五月失去动力的地方，买家再次开始介入。在过去一周，股价在 30 美元水平上强劲反弹，这表明大型资金可能正在悄然建立头寸。</p>
<p>动量指标也开始向多头倾斜。相对强弱指数（RSI）已从深度超卖区域反弹，而该股票的 MACD 即将出现看涨交叉。在经历了近四年的下行压力后，Global Medical 的图表显示出早期的低点形成迹象。对于我们这些在场外观察的人来说，这为一个有趣的入场点提供了机会。</p>
<h2>分析师再次转向看涨</h2>
<p>华尔街情绪的持续转变正在帮助加强这一论点。本周早些时候，Citizens JMP 将对 Global Medical 的评级从 <strong>市场表现</strong> 上调至 <strong>跑赢大盘</strong>，并设定了 40 美元的新目标价。从周三晚上的收盘价来看，这指向了近 30% 的上涨空间。</p>
<p>他们的看涨更新与 Zacks Research 的观点相呼应，后者上个月将 Global Medical 的评级上调至 <strong>强烈买入</strong>，突显了分析师社区日益增长的乐观情绪。似乎达成了一致，即大部分下行风险现在已经被考虑在内，而公司的资产负债表改善和支持性的宏观经济背景是看涨的理由。</p>
<p>事实上，REITs 的整体环境开始改善。对进一步降息的预期减轻了对收益敏感的股票（如 Global Medical）的压力，而他们最近宣布的 5000 万美元股票回购计划则增加了另一层支持。</p>
<p>新任首席执行官对去杠杆化的关注表明，公司决心翻开过去几年对股东来说痛苦的篇章。</p>
<p>对于考虑在 30 美元附近参与的投资者来说，公司的 9.31% 股息收益率显得特别诱人。</p>
<p>即使复苏需要时间，它也提供了一个有吸引力的收入来源。</p>
<h2>风险依然存在，但前景令人信服</h2>
<p>与此同时，仍然存在需要考虑的风险。Global Medical 对利率变动高度敏感，尽管美联储正处于放松周期，但这一切的时机仍然不确定。公司还面临着来自投资者的持续怀疑，他们看到自己的股票在广泛市场在过去夏季创下新高的同时继续下跌。</p>
<p>尽管如此，在这些水平上，风险/回报的平衡看起来是有利的。在经历了 60% 的峰值到谷底的下跌后，大部分坏消息可能已经被定价，而最近的分析师升级表明情绪开始转变。</p>
<p>如果股价在十月剩余时间内能够保持在 30 美元以上，这将确认一个持久的底部已经形成。从那里来看，技术面和分析师目标指向年底有显著反弹的空间。</p>
<h2>你现在应该投资 1000 美元在 Global Medical REIT 吗？</h2>
<p>在考虑 Global Medical REIT 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场意识到之前买入……而 Global Medical REIT 并不在名单上。</p>
<p>虽然 Global Medical REIT 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

GMRE

<p>全球医疗房地产投资信托（Global Medical REIT）的股价大幅下跌，自 2021 年 12 月以来损失超过 60%。然而，最近的分析师升级，包括来自 Citizens JMP 的新目标价 40 美元，暗示潜在的复苏。该股票在 30 美元附近找到了支撑，出现了看涨的动量指标。尽管与利率和投资者怀疑相关的风险依然存在，但公司 9.31% 的股息收益率和改善的资产负债表使其成为收入投资者的一个有吸引力的选择。分析师认为，许多下行风险已经被考虑在内，表明其风险/收益特征较为有利</p>

<p>Real Estate Investment Trusts, or REITs, are often a favorite among income investors. They offer regular dividends, provide easy exposure to tangible assets, and can serve as a natural hedge against inflation. Within that universe, <strong>Global Medical REIT</strong> <strong>Inc. NYSE: GMRE</strong> stands out as a niche player focused on healthcare properties. Its portfolio includes medical office buildings, outpatient facilities, and specialty care centers—all backed by long-term leases and stable tenants.</p>
<div class="lb-trans"><p>房地产投资信托基金（REITs）通常是收入投资者的最爱。它们提供定期分红，便于接触有形资产，并且可以作为对抗通货膨胀的自然对冲。在这个领域中，<strong>Global Medical REIT</strong> <strong>Inc. NYSE: GMRE</strong> 作为一个专注于医疗物业的细分市场参与者脱颖而出。其投资组合包括医疗办公楼、门诊设施和专科护理中心——所有这些都由长期租约和稳定的租户支持。</p>
</div><p>Frustratingly for investors, however, while this brick-and-mortar stability looks good on paper, it hasn’t helped Global Medical much in recent years. Its shares have been in a persistent decline since December 2021, losing more than 60% of their value. As we’ll see below, several factors contributed to this, and the stock hit fresh all-time lows earlier this month.</p>
<div class="lb-trans"><p>然而，对于投资者来说，令人沮丧的是，尽管这种实体稳定在纸面上看起来不错，但近年来对 Global Medical 的帮助不大。自 2021 年 12 月以来，其股价持续下跌，价值损失超过 60%。正如我们下面将看到的，多个因素导致了这一情况，并且该股票在本月早些时候创下了历史新低。</p>
</div><p>Get <strong>Global Medical REIT</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Global Medical REIT</strong> 的提醒：</p>
</div><p>But after years of relentless selling, there are finally signs of a bottom forming. With several analysts starting to turn bullish and the technical picture improving, there are reasons to think that Global Medical’s long-awaited recovery is finally taking shape. Let’s jump in and take a closer look.</p>
<div class="lb-trans"><p>但经过多年的持续抛售，终于出现了底部形成的迹象。随着几位分析师开始转向看涨，技术面也在改善，有理由认为 Global Medical 期待已久的复苏终于开始成形。让我们深入了解一下。</p>
</div><h2>A Brutal Downtrend, But a Clear Floor Emerging</h2>
<div class="lb-trans"><h2>残酷的下行趋势，但明确的底部正在出现</h2>
</div><p>Much of the stock’s decline can be attributed to higher interest rates and investor skepticism toward debt-heavy real estate names, which made the bears particularly fond of Global Medical. It didn’t help that leadership was forced to trim its dividend by 29% earlier this year, which shook investor confidence just as the stock was consolidating.</p>
<div class="lb-trans"><p>股票下跌的主要原因可以归因于更高的利率和投资者对负债沉重的房地产公司的怀疑，这使得空头特别青睐 Global Medical。今年早些时候，管理层被迫将股息削减 29%，这在股票整合时动摇了投资者的信心。</p>
</div><p>But the stock may have found its floor despite having slid further since then. The $30 level has now emerged as a critical line of support; it’s where the bears ran out of steam last May, and buyers have been once again stepping in. Over the past week, shares have bounced hard off the $30 level, suggesting that big money funds might be quietly building up positions.</p>
<div class="lb-trans"><p>但尽管此后股价进一步下滑，该股票可能已经找到了底部。30 美元的水平现在已成为一个关键的支撑线；这是空头在去年五月失去动力的地方，买家再次开始介入。在过去一周，股价在 30 美元水平上强劲反弹，这表明大型资金可能正在悄然建立头寸。</p>
</div><p>Momentum indicators are also starting to turn in favor of the bulls. The RSI has rebounded from deeply oversold territory, while the stock’s MACD is on the verge of a bullish crossover. After nearly four years of downward pressure, Global Medical’s chart shows early signs of putting in a low. For those of us on the sidelines, that makes for an interesting entry point.</p>
<div class="lb-trans"><p>动量指标也开始向多头倾斜。相对强弱指数（RSI）已从深度超卖区域反弹，而该股票的 MACD 即将出现看涨交叉。在经历了近四年的下行压力后，Global Medical 的图表显示出早期的低点形成迹象。对于我们这些在场外观察的人来说，这为一个有趣的入场点提供了机会。</p>
</div><h2>Analysts Are Turning Bullish Again</h2>
<div class="lb-trans"><h2>分析师再次转向看涨</h2>
</div><p>An ongoing shift in Wall Street sentiment is helping to strengthen that case. Earlier this week, Citizens JMP upgraded its rating on Global Medical from <strong>Market Perform to Outperform</strong> while setting a new price target of $40. From where the stock closed on Wednesday evening, that’s pointing to a targeted upside of nearly 30.</p>
<div class="lb-trans"><p>华尔街情绪的持续转变正在帮助加强这一论点。本周早些时候，Citizens JMP 将对 Global Medical 的评级从 <strong>市场表现</strong> 上调至 <strong>跑赢大盘</strong>，并设定了 40 美元的新目标价。从周三晚上的收盘价来看，这指向了近 30% 的上涨空间。</p>
</div><p>Their bullish update echoed that of Zacks Research, which upped its rating on Global Medical to Strong Buy last month, highlighting growing optimism across the analyst community. There appears to be a consensus that much of the downside has now been factored in, and the company’s improving balance sheet and supportive macroeconomic backdrop are reasons to be bullish.</p>
<div class="lb-trans"><p>他们的看涨更新与 Zacks Research 的观点相呼应，后者上个月将 Global Medical 的评级上调至 <strong>强烈买入</strong>，突显了分析师社区日益增长的乐观情绪。似乎达成了一致，即大部分下行风险现在已经被考虑在内，而公司的资产负债表改善和支持性的宏观经济背景是看涨的理由。</p>
</div><p>Indeed, the broader environment for REITs is starting to improve. Expectations of further interest-rate cuts relieve yield-sensitive stocks, such as Global Medical, while their recently announced $50 million share repurchase program adds another layer of support.</p>
<div class="lb-trans"><p>事实上，REITs 的整体环境开始改善。对进一步降息的预期减轻了对收益敏感的股票（如 Global Medical）的压力，而他们最近宣布的 5000 万美元股票回购计划则增加了另一层支持。</p>
</div><p>Their new CEO’s focus on deleveraging shows the company is intent on turning the page on what’s been a painful few years for shareholders.</p>
<div class="lb-trans"><p>新任首席执行官对去杠杆化的关注表明，公司决心翻开过去几年对股东来说痛苦的篇章。</p>
</div><p>For investors thinking about getting involved around the $30 mark, the company’s 9.31% dividend yield looks particularly compelling.</p>
<div class="lb-trans"><p>对于考虑在 30 美元附近参与的投资者来说，公司的 9.31% 股息收益率显得特别诱人。</p>
</div><p>It provides an attractive income stream even if the recovery takes time.</p>
<div class="lb-trans"><p>即使复苏需要时间，它也提供了一个有吸引力的收入来源。</p>
</div><h2>Risks Remain, But The Setup Is Compelling</h2>
<div class="lb-trans"><h2>风险依然存在，但前景令人信服</h2>
</div><p>At the same time, there are still risks to consider. Global Medical remains highly sensitive to interest-rate movements, and while the Fed is in a softening cycle, the timing of all this remains uncertain. The company also faces lingering skepticism from investors who’ve watched their shares continue to sell off while the broader market posted high after high this past summer.</p>
<div class="lb-trans"><p>与此同时，仍然存在需要考虑的风险。Global Medical 对利率变动高度敏感，尽管美联储正处于放松周期，但这一切的时机仍然不确定。公司还面临着来自投资者的持续怀疑，他们看到自己的股票在广泛市场在过去夏季创下新高的同时继续下跌。</p>
</div><p>Still, the risk/reward balance looks favorable at these levels. After a 60% peak-to-trough decline, much of the bad news has likely been priced in, and the recent analyst upgrades suggest sentiment is starting to shift.</p>
<div class="lb-trans"><p>尽管如此，在这些水平上，风险/回报的平衡看起来是有利的。在经历了 60% 的峰值到谷底的下跌后，大部分坏消息可能已经被定价，而最近的分析师升级表明情绪开始转变。</p>
</div><p>If shares can hold above $30 through the rest of October, it would confirm that a durable base has formed. From there, the technicals and analyst targets point to room for a meaningful rebound into year-end.</p>
<div class="lb-trans"><p>如果股价在十月剩余时间内能够保持在 30 美元以上，这将确认一个持久的底部已经形成。从那里来看，技术面和分析师目标指向年底有显著反弹的空间。</p>
</div><h2>Should You Invest $1,000 in Global Medical REIT Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Global Medical REIT 吗？</h2>
</div><p>Before you consider Global Medical REIT, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Global Medical REIT 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场意识到之前买入……而 Global Medical REIT 并不在名单上。</p>
</div><p>While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Global Medical REIT 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Global Medical：这个 REIT 刚刚获得了 30% 的目标价